Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohorts
By K. Matsushita, Marije van der Velde, B. Astor, M. Woodward, A. Levey, P. D. de Jong, Josef Coresh, R. Gansevoort. The Lancet, 2010
3,638 citations recorded by the source corpus.
Background A comprehensive evaluation of the independent and combined associations of estimated glomerular filtration rate (eGFR) and albuminuria with mortality is required for assessment of the impact of kidney function on risk in the general population, with implications for improving the definition and staging of chronic kidney disease (CKD). Methods A collaborative meta-analysis of general population cohorts was undertaken to pool standardized data for all-cause and cardiovascular mortality. The two kidney measures and potential confounders from 14 studies (105,872 participants; 730,577 person-years) with urine albumin-to-creatinine ratio (ACR) measurements and seven studies (1,128,310 participants; 4,732,110 person-years) with urine protein dipstick measurements were modeled. Findings In ACR studies, mortality risk was unrelated to eGFR between 75-105 ml/min/1·73 m2 and increased at lower eGFR. Adjusted hazard ratios (HRs) for all-cause mortality at eGFR 60, 45, and 15 (versus 95) ml/min/1·73 m2 were 1·18 (95% CI: 1·05-1·32), 1·57 (1·39-1·78), and 3·14 (2·39-4·13), respectively. ACR was associated with mortality risk linearly on the log-log scale without threshold effects. Adjusted HRs for all-cause mortality at ACR 10, 30, and 300 (versus 5) mg/g were 1·20 (1·15-1·26), 1·63 (1·50-1·77), and 2·22 (1·97-2·51). eGFR and ACR were multiplicatively associated with mortality without evidence of interaction. Similar findings were observed for cardiovascular mortality and in dipstick studies. Interpretation Lower eGFR (<60 ml/min/1·73 m2) and higher albuminuria (ACR ≥10 mg/g) were independent predictors of mortality risk in the general population. This study provides quantitative data for using both kidney measures for risk evaluation and CKD definition and staging.
Subfields: Nephrology, Oncology
View Paper: https://www.semanticscholar.org/paper/115f88496b85a8807517d357526f1bfbfe2844e8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Nephrology
- A. Levey
- Josef Coresh
- Marcello Tonelli
- Harold I. Feldman
- A. Levin
- R. Gansevoort
- Giuseppe Remuzzi
- R. Mehta
Citations in the corpus
- Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations (2023, background): “…investigations have previously incorporated kidney measures in risk prediction but have demonstrated their predictive utility separately for ASCVD and HF in the general population and among people with CKD. 38,51,72 The add-on PREVENT models consider UACR when clinically indicated and available.”
- ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “Both in the general population and in diabetic patients, the concomitance of an increased urinary protein excretion and a reduced eGFR indicates a greater risk of CV and renal events than either abnormality alone, making these risk factors independent and cumulative.(227,228) An arbitrary threshold ”